Evidence map›Paper›PMID 26202217›Full record

ArticleBMC bioinformatics2015

Knowledge transfer via classification rules using functional mapping for integrative modeling of gene expression data.

Henry A Ogoe, Shyam Visweswaran, Xinghua Lu, Vanathi Gopalakrishnan

Abstract read
In one paragraph

Article in BMC bioinformatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Henry A OgoeDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, USA. hao9@pitt.edu.
Shyam VisweswaranDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, USA. shv3@pitt.edu.
Xinghua LuDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, USA. xinghua@pitt.edu.
Vanathi GopalakrishnanDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, USA. vanathi@pitt.edu.

Funding

Vitamin D3 Modulation of Inflammation and Lung Cancer RiskP50CA090440 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIEGFRIED, JILL M · 2001 to 2015
$34.6M
The internship in Biomedical Research, Informatics, and Computer Science (iBRIC): Biomedical Informatics and Data Science research experiences for students from Minority Serving InstitutionsT15LM007059 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARRY S HOCHHEISER · 1987 to 2026
$23.9M
Interpretable deep learning models for translational medicine RenewalR01LM012011 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Tanner J. Freeman, XINGHUA LU · 2015 to 2026
$3.6M
Transfer Rule Learning with Functional Mapping for Integrative Modeling of Panomics DataR01GM100387 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOPALAKRISHNAN, VANATHI · 2012 to 2018
$1.8M
Ontology-Driven Methods for Knowledge Acquisition and Knowledge DiscoveryR01LM011155 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LU, XINGHUA · 2011 to 2014
$1.2M
NCI NIH HHS P50 CA090440NCI NIH HHS P50CA90440NIGMS NIH HHS R01 GM100387NIGMS NIH HHS R01GM100387NLM NIH HHS 5R01LM011155-04NLM NIH HHS 5T15LM007059-26NLM NIH HHS R01 LM011155NLM NIH HHS R01 LM012011NLM NIH HHS T15 LM007059
6 · The paper itself

Abstract

backgroundMost 'transcriptomic' data from microarrays are generated from small sample sizes compared to the large number of measured biomarkers, making it very difficult to build accurate and generalizable disease state classification models. Integrating information from different, but related, 'transcriptomic' data may help build better classification models. However, most proposed methods for integrative analysis of 'transcriptomic' data cannot incorporate domain knowledge, which can improve model performance. To this end, we have developed a methodology that leverages transfer rule learning and functional modules, which we call TRL-FM, to capture and abstract domain knowledge in the form of classification rules to facilitate integrative modeling of multiple gene expression data. TRL-FM is an extension of the transfer rule learner (TRL) that we developed previously. The goal of this study was to test our hypothesis that "an integrative model obtained via the TRL-FM approach outperforms traditional models based on single gene expression data sources".

resultsTo evaluate the feasibility of the TRL-FM framework, we compared the area under the ROC curve (AUC) of models developed with TRL-FM and other traditional methods, using 21 microarray datasets generated from three studies on brain cancer, prostate cancer, and lung disease, respectively. The results show that TRL-FM statistically significantly outperforms TRL as well as traditional models based on single source data. In addition, TRL-FM performed better than other integrative models driven by meta-analysis and cross-platform data merging.

conclusionsThe capability of utilizing transferred abstract knowledge derived from source data using feature mapping enables the TRL-FM framework to mimic the human process of learning and adaptation when performing related tasks. The novel TRL-FM methodology for integrative modeling for multiple 'transcriptomic' datasets is able to intelligently incorporate domain knowledge that traditional methods might disregard, to boost predictive power and generalization performance. In this study, TRL-FM's abstraction of knowledge is achieved in the form of functional modules, but the overall framework is generalizable in that different approaches of acquiring abstract knowledge can be integrated into this framework.

Indexed as

AlgorithmsModels, GeneticBiomarkersDatabases, FactualGene ExpressionHumansNeoplasmsBiomarkers

Identifiers

PMID26202217
PMCPMC4512094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.